- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BEACON Pharmaceutical Ltd (BEAC)
Track today's live BEACON Pharma (BEAC) share price, performance and key data on this page with our current DSE:BEAC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the BEACON Pharma share price on the DSE exchange. Use the dropdown to switch exchange for the BEAC share price, head to our technical summary section, which provides analysis on BEACON Pharma share price buy/sell indicators using real-time data (or discuss the BEACON Pharma (BEAC) stock price today with other investors in the BEACON Pharma DH share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current DH:BEAC share price (ISIN: BD0482BECON5) to enhance your trading decisions with our free investment tools and resources.
What Is the BEACON Pharmaceutical Ltd Share Price Today?
The BEACON Pharma share price today is 107.70.
What Is the Stock Symbol for BEACON Pharmaceutical Ltd
The stock symbol (or 'ticker') for BEACON Pharmaceutical Ltd is "BEAC."
What Stock Exchange Does BEACON Pharmaceutical Ltd Trade On?
BEACON Pharmaceutical Ltd is listed and trades on the DSE stock exchange.
Is BEACON Pharmaceutical Ltd a Good Stock to Buy?
Determining whether BEACON Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current DH:BEAC share price (ISIN: BD0482BECON5) to enhance your trading decisions with our free investment tools and resources.
What Is the BEACON Pharmaceutical Ltd Share Price Today?
The BEACON Pharma share price today is 107.70.
What Is the Stock Symbol for BEACON Pharmaceutical Ltd
The stock symbol (or 'ticker') for BEACON Pharmaceutical Ltd is "BEAC."
What Stock Exchange Does BEACON Pharmaceutical Ltd Trade On?
BEACON Pharmaceutical Ltd is listed and trades on the DSE stock exchange.
Is BEACON Pharmaceutical Ltd a Good Stock to Buy?
Determining whether BEACON Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
DSE
Currency in BDT
107.70
-0.90(-0.83%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.40
109.50
52 wk Range
96.00
147.50
BEAC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.40109.50
52 wk Range
96.00147.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.69%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BEAC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
01/06/2026
EPS / Forecast
1.22 / --
Revenue / Forecast
3.8B / --
Compare BEAC to Peers and Sector
Metrics to compare | BEAC | Peers Peers - average of corresponding metrics from companies closely matching BEAC: NAVANAPHAR, IBNSINA, ACMELAB, RENATA, BXPHARMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBEACPeersSector |
|---|---|---|---|---|
P/E Ratio | 17.1x | 7.5x | −0.4x | |
PEG Ratio | 0.23 | −1.37 | 0.00 | |
Price/Book | 3.2x | 1.5x | 2.6x | |
Price / LTM Sales | 1.6x | 3.3x | 3.1x | |
Upside (Analyst Target) | - | 30.5% | 48.8% | |
Fair Value Upside | Unlock | −2.9% | 5.7% | Unlock |
Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestinal, infectious diseases, immunology, rheumatology, muscle relaxants, antihistamines, anti-coagulants, protein supplements, pediatrics, NSAIDs, nutritional supplements, and others. In addition, the company offers contract and toll manufacturing services. It provides its products under the Pemro, Nivomab, Xelpac Premium, Docexan, Xaloplat Aqua, Gemoxen Aqua, ETP, FXR, Renesis, Mezest, Eposis, Tirza, Xelmet, Xerova, Sinjard, Ovocal, Haxinor, Tetrazin, Lubilux, Paloxi, Olonex, Gaviflux, Mirogab, Flexibac, and Bukof brand name. Beacon Pharmaceuticals PLC was incorporated in 2001 and is based in Dhaka, Bangladesh.
FAQ
What Is the BEACON Pharma (DSE: BEAC) Share Price Today?
The BEACON Pharma stock price today is 107.70 BDT.
What Stock Exchange Does BEACON Pharma (BEAC) Trade On?
BEACON Pharma is listed and trades on the Dhaka Stock Exchange.
What Is the Ticker (Stock Symbol) for BEACON Pharma?
The stock symbol (also called a 'ticker') for BEACON Pharma is "BEAC."
Does BEACON Pharma Pay Dividends? What’s The Current BEAC Dividend Yield?
Yes, BEAC Pays Dividends to its Shareholders. The current BEACON Pharma dividend yield is 1.69%.
What Is the Current BEACON Pharma Market Capitalisation?
As of today, BEACON Pharma (DSE: BEAC) market cap is 24.88B BDT.
What Is BEACON Pharma's (BEAC) Earnings Per Share (TTM)?
The BEACON Pharma EPS is currently 6.31 (Trailing Twelve Months).
Is BEAC a Buy or Sell From a Technical Analyst Perspective?
Based on today's BEACON Pharma moving averages and other technical indicators, the daily buy/sell signal for BEAC stock is Strong Sell.
How Many Times Has BEACON Pharma Stock Split?
BEACON Pharma has split 1 times. (See the BEAC stock split history page for full effective split date and price information.)
How Many Employees Does BEACON Pharma Have?
BEACON Pharma has 4771 employees, based on their latest Companies House report.
What is the current trading status of BEACON Pharma (DSE: BEAC)?
As of 09/08/2026, BEACON Pharma (BEAC) is trading at a share price of 107.70 BDT, with a previous close of 124.30 BDT. The stock has fluctuated within a day range of 107.40 BDT to 109.50 BDT, while its 52-week range spans from 96.00 BDT to 147.50 BDT.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.